REGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

Martin Broto, J.Valverde, C.Hindi, N.Vincenzi, B.Martinez-Trufero, J.Grignani, G.Italiano, A.Lavernia, J.Gonzalez-Campora, R.Vallejo, A.Hernandez-Jover, D.Gutierrez, A.Serrano, C.Moura, D.Lopez-Guerrero, J. A.Cruz, J.Fernandez-Serra, A.Blay, J-Y.Fumagalli, E. R.Martinez Marin, V.2025-01-072025-01-072021-09-210923-7534https://hdl.handle.net/10668/27621enREGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialconference outputopen access10.1016/j.annonc.2021.08.8501569-8041https://doi.org/10.1016/j.annonc.2021.08.850700527703067